Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Int Immunopharmacol. 2014 Mar 6;20(1):157–163. doi: 10.1016/j.intimp.2014.02.029

Figure 1. Modest change in survival post treatment with rmLF after lethal challenge with MRSA.

Figure 1

BALB/c mice were infected IP with MRSA (LD100) were treated at 2 hours post-infection with rmLF (100µg/mouse). Survival was monitored post-infection. Control (non-treated) mice succumbed to MRSA infection within 24 hours. Mice treated with rmLF demonstrated increased survival. Data representative of two experimental repeats with 8 mice per experiment.